Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
ADAM15 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM15, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM12 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM12, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM11 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM11, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM9 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM9, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAM2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAM2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAD2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAD2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADAD1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADAD1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ADA2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ADA2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACYP2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ACYP2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACYP1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
24 July 2026
A visual target evaluation report for ACYP1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.